AWHL
Aspira Women's Health Inc.Company with tickers: AWHL
CIK
926617
Shares Outstanding
43,500,411
Website
https://www.aspirawh.com
Investor Relations
https://ir.aspirawh.com/
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $32,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | $1,967,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | $1,071,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Expenses | $3,274,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $1,226,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-2,203,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $676,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.05 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Single Reportable Segment | $9,182,000 | $9,216,000 |
By Product & Service (USD)
| Component | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| Product | $4,543,000 | $6,568,000 | $7,970,000 | $9,153,000 | $9,182,000 | $9,216,000 |
| Genetics | $108,000 | $244,000 | $214,000 | — | — | — |
| Genetics | — | — | — | $1,000 | — | — |